(Bloomberg) -- Goldman Sachs Group Inc. and other major banks boosted their forecasts for China’s 2025 economic growth, citing a better outlook for exports following the tariff truce with the US. Most Read from Bloomberg As Coastline Erodes, One California City Considers ‘Retreat Now’ A New Central Park Amenity, Tailored to Its East Harlem Neighbors What’s Behind the Rise in Serious Injuries on New York City’s Streets? How Finland Is Harvesting Waste Heat From Data Centers Lawsuit Challenges Trump Administration Policy on Migrant Children Economists at Goldman Sachs, JPMorgan Chase & Co., ING Groep NV and Bloomberg Economics this week lifted their projections to 4.6% or above from as low as 4% previously. China could avoid a contraction in exports this year after striking a temporary deal with the US to de-escalate their trade conflict, Goldman said in a note Tuesday. In what could disappoint markets, the rosier outlook reduces the amount of additional stimulus policymakers might need to roll out to cushion the tariff impact, such as greater government borrowing and spending. Chinese stocks fell in Hong Kong on Tuesday as initial optimism from the truce faded, before rising again on Wednesday morning. JPMorgan on Monday removed its forecast for 1 trillion yuan ($139 billion) worth of fiscal stimulus it previously foresaw around a July meeting of the elite Politburo. Goldman Sachs now expects only one 10-basis point policy rate cut in the rest of this year, instead of two reductions of the same size previously. What Bloomberg Economics Says... “Working out the details of a trade agreement will be fraught and could take time. For now, China has secured some breathing room — valuable time as it races to develop high-tech industries and bolster domestic demand to reduce the economy’s vulnerability to external shocks. Ultimately, the extent China is able to lift consumption and investment will determine the longer-term growth path.” — Chang Shu and David Qu Click here to read the full report. Chinese and US trade negotiators on Monday announced an agreement to lower additional tariffs imposed during Trump’s second term by more than anticipated, broadly taking China’s blanket tariffs on US goods to 10% and US levies on China to 30% during a 90-day period. As a result, the average US tariff rate on China has fallen to around 40% from about 110% previously, according to Bloomberg Economics estimates. The tariff truce will likely boost Chinese exports in the coming months as US importers rush to fill their depleted inventories and front-load more orders. Story Continues “China’s exports will likely accelerate further in the next 90 days. How overseas shipments will evolve after that will depend on where the trade talks go next,” said Zhou Mi, a senior research fellow with the Chinese Academy of International Trade and Economic Cooperation, a think tank under China’s Ministry of Commerce. Beijing will seek to lower US tariffs further as they are “still very high,” according to Zhou. “The rate is still targeted at China and different from other countries. It is not a reasonable one from the very beginning,” he said. JPMorgan’s forecasts are based on the assumption that the temporary tariff reduction will stay for the rest of this year, although its economists acknowledged the uncertainty over the outcome of the trade talks. There’s room for the 20% fentanyl-related tariffs imposed by Trump on China to be lowered if China takes serious measures to curb the drug’s flow, JPMorgan economists including Zhu Haibin wrote in a report dated Monday. “On the other hand, the bar for a potential deal between China and the US is high and it could take much longer than 90 days, so we should not rule out the possibility of resurgence of tariff increase,” they said. Analysts at other major lenders including Citigroup Inc. and UBS Group AG have also cited upside potential to their current outlook for the Chinese economy following the trade talks in Geneva. --With assistance from Fran Wang. (Updates with details and comments throughout.) Most Read from Bloomberg Businessweek Cartoon Network’s Last Gasp DeepSeek’s ‘Tech Madman’ Founder Is Threatening US Dominance in AI Race Trump Has Already Ruined Christmas Why Obesity Drugs Are Getting Cheaper — and Also More Expensive The Recession Chatter Is Getting Louder. Watch These Metrics ©2025 Bloomberg L.P. View Comments
Wall Street Sees Higher China Growth, Less Stimulus on US Truce
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...